Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma

Journal of Pediatric Surgery

Volumn 42, Issue 1, 2007, Pages 148-152

  Vasudevan, Sanjeev A ^a   Russell, Heidi V ^a   Okcu, M Fatih ^a   Burlingame, Susan M ^a   Liu, Zhiyun J ^a   Yang, Jianhua ^a   Nuchtern, Jed G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

High risk disease; NDSP; Neuroblastoma; Quantitative RT PCR

Indexed keywords

MESSENGER RNA; SECRETORY PROTEIN; TUMOR MARKER;

ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MALE; MOLECULAR CLONING; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

ADULT; FEMALE; HUMANS; INFANT; MALE; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEUROBLASTOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 33845947980     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2006.09.064     Document Type: Article

References (16)

1. Brodeur G.M., and Maris J.M. Neuroblastoma. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 4th ed (2002), Lippincott Williams & Wilkins, Philadelphia (Pa) 895-937
2. Beiske K., Ambros P.F., Burchill S.A., et al. Detecting minimal residual disease in neuroblastoma patients-the present state of the art. Cancer Lett 28 (2005) 229-240
3. Cheung I.Y., Sahota A., and Cheung N.K. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis. Cancer 101 (2004) 2303-2308
4. Cheung I.Y., Lo Piccolo M.S., Kushner B.H., et al. Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma. J Clin Oncol 21 (2003) 3853-3858
5. Cheung I.Y., Lo Piccolo M.S., Kushner B.H., et al. Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma. J Clin Oncol 21 (2003) 1087-1093
6. Pagani A., Macri L., Faulkner L.B., et al. Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology. Diagn Mol Pathol 11 (2002) 98-106
7. Vasudevan S.A., Nuchtern J.G., and Shohet J.M. Gene profiling of high risk neuroblastoma. World J Surg 29 (2005) 317-324
8. Cristofanilli M., Budd G.T., Ellis M.J., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351 (2004) 781-791
9. Moreno J.G., Miller M.C., Gross S., et al. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology 65 (2005) 713-718
10. Oberg A.N., Lindmark G.E., Israelsson A.C., et al. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAs. Int J Cancer 111 (2004) 101-110
11. Wharton R.Q., Jonas S.K., Glover C., et al. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 5 (1999) 4158-4163
12. Jotsuka T., Okumura Y., Nakano S., et al. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer. Surgery 135 (2004) 419-426
13. Nebozhyn M., Loboda A., Kari L., et al. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5-99% circulating tumor cells with 90% accuracy. Blood 107 (2006) 3189-3196
14. Santini D., Tonini G., Vincenzi B., et al. Skin lesions in melanoma and Kaposi's sarcoma. Case 1. Detection of circulating malignant cells by RT-PCR in a case of cutaneous melanoma in complete regression. J Clin Oncol 20 (2002) 1411-1412
15. Shimazui T., Yoshikawa K., Uemura H., et al. Detection of cadherin-6 mRNA by nested RT-PCR as a potential marker for circulating cancer cells in renal cell carcinoma. Int J Oncol 23 (2003) 1049-1054
16. De Luca A., Pignata S., Casamassimi A., et al. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay. Clin Cancer Res 6 (2000) 1439-1444